Musculoskeletal Clinical Regulatory Advisers

Executive Summary

MCRA is a leading global Clinical Research Organization (CRO) and consulting firm specializing in medical devices, diagnostics, and biologics, with a particular focus on musculoskeletal and regenerative medicine. Founded in 2004 and headquartered in Washington, D.C., MCRA integrates regulatory, clinical research, reimbursement, healthcare compliance, quality assurance, and distribution logistics services to guide products from conception to commercialization. The company serves over 850 MedTech companies annually across more than 1,700 projects, positioning itself as a critical partner for navigating complex regulatory pathways. Despite being private, MCRA's comprehensive service offering and deep expertise in musculoskeletal and regenerative therapeutics make it a key enabler in the MedTech ecosystem. With no disclosed funding or valuation, the company's stability and growth are inferred from its extensive client base and project volume. MCRA's conviction score reflects its essential but service-oriented role, which limits direct investment catalysts but underscores its strategic importance.

Upcoming Catalysts (preview)

• Q4 2026New FDA Guidance on Regenerative Medicine Products75% success
• Q2 2027Expansion into Neuromodulation and Digital Health60% success
• TBDStrategic Acquisition by a Larger CRO or Consulting Firm30% success